Ownership history in MORGAN STANLEY · 10 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in ANEBULO PHARMACEUTICALS INC (ANEB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 399,404 | — | 0% | 0.00% | $403K | $1.01 |
| 2025 Q3 | ADDED | 399,404 | +185 | +0.0% | 0.00% | $999K | $2.50 |
| 2025 Q2 | UNCHANGED | 399,219 | — | 0% | 0.00% | $575K | $1.44 |
| 2025 Q1 | REDUCED | 399,219 | -20,775 | -4.9% | 0.00% | $519K | $1.30 |
| 2024 Q4 | ADDED | 419,994 | +20,775 | +5.2% | 0.00% | $706K | $1.68 |
| 2024 Q3 | UNCHANGED | 399,219 | — | 0% | 0.00% | $770K | $1.93 |
| 2024 Q2 | UNCHANGED | 399,219 | — | 0% | 0.00% | $1.1M | $2.73 |
| 2024 Q1 | UNCHANGED | 399,219 | — | 0% | 0.00% | $1.1M | $2.87 |
| 2023 Q4 | ADDED | 399,219 | +398,619 | +66436.5% | 0.00% | $966K | $2.42 |
| 2022 Q3 | INITIATED | 600 | — | — | 0.00% | $2K | $2.80 |
As of 2025 Q4 — sorted by position size